1. Home
  2. > Pharmaceutical
  3. > Biopharmaceutical Market Trends
Recombinant Proteins Market by Product, Application, End User - Global Forecast to 2027

Recombinant Proteins Market by Product, Application, End User - Global Forecast to 2027

  • November 2022
  • 237 pages
  • ID: 6028027
  • Format: PDF
  • MarketsandMarkets


Table of Contents

Search Inside

The global recombinant proteins market is projected to reach USD 2.4 billion by 2027 from USD 1.4 billion in 2022, at a CAGR of 11.4% during the forecast period. The market growth is primarily driven by factors such as increasing government investments and R&D expenditure in pharmaceutical & biotechnology companies and academic research institutes alongside the high prevalence of chronic and infectious diseases resulting in the need for recombinant proteins for crucial diagnostics. However, flocking to the market with competitively priced products and labor-intensive processes with low yields of recombinant protein may restrict market growth to a certain extent

The pharmaceutical & biopharmaceutical companies segment is expected to dominate the market during the forecast period.
Based on end users, the recombinant proteins market is segmented into pharmaceutical & biopharmaceutical companies, biotechnology companies, academic research institutes, contract research organizations, and other end users.Pharmaceutical & biopharmaceutical companies accounted for the largest share of the end user market in 2020.

The large share of this segment is attributed to the role of recombinant proteins as a crucial component of most small molecule drug discovery programs, as well as the requirement of recombinant protein in drug discovery for the screening of the structural and mechanistic studies of new drug applications. Also, factors such as the patent expiration of blockbuster drugs impact the market growth positively.

Vaccine segment will witness the second highest growth in the recombinant proteins market during the forecast period.
Based on type, the drug discovery & development market is segmented into biologics, vaccines, and cell & gene therapy.Vaccine accounted for the second largest share of the drug discovery & development application for the recombinant proteins market and is expected to register the second highest CAGR during the forecast period. The large share of the vaccine segment is attributed to the factors such increased incidence of diseases such as influenza, viral diseases and hepatitis. The emergence of such diseases has led to increased R&D activities to discover proactive vaccine and this is fueling the market growth for recombinant protein.

North America will dominate the market during the forecast period.
Geographically, the recombinant proteins market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.In 2021, North America accounted for the largest share of the recombinant proteins market.

The large share of this region in the global market is attributed to the rising prevalence of infectious diseases and chronic conditions, growing R&D spending by the government and pharmaceutical industry, increasing research activities by biotechnology firms, and the presence of key market players.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type - Tier 1: 36%, Tier 2: 45%, and Tier 3: 19%
• By Designation - C-level: 33%, D-level: 40%, and Others: 27%
• By Region - North America: 36%, Europe: 28%, Asia Pacific: 19%, Latin America: 10%, and Middle East and Africa 7%.

List of Companies Profiled in the Report
• Thermo Fisher Scientific Inc. (US)
• Miltenyi Biotech (Germany)
• Sino Biological Inc. (China)
• Merck KGaA (Germany)
• Abcam plc (UK)
• Biolegend (US)
• Bio-Rad Laboratories, Inc. (US)
• GenScript Biotech Corporation (China)
• Enzo Life Sciences, Inc. (US)
• BPS Bioscience, Inc. (US)
• Proteintech Group, Inc. (US)
• Abnova Corporation (Taiwan)
• R&D Systems (US)
• STEMCELL Technologies Inc (Canada)
• RayBiotech Inc (US)
• CellGenix GmbH (Germany)
• ACROBiosystems (US)
• ProSpec-TechnoGene Ltd. (Israel)
• Neuromics (US)
• Lauraus Bio (India)
• Icosagen AS (US)
• ProteoGenix (France)
• United States Biological (US)
• StressMarq Biosciences Inc (Canada)
• Aviva Systems Biology Corporation (US)

Research Coverage:
This report provides a detailed picture of the global recombinant proteins market.It aims at estimating the size and future growth potential of the market across different segments, such as product, application, end user, and region.

The report also analyzes factors (such as drivers, restraints, challenges, and opportunities) affecting the market growth.It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders.

The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total recombinant proteins market. The report forecasts the revenue of the market segments with respect to five major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on recombinant proteins offered by the top 25 players in the recombinant proteins market. The report analyses the recombinant proteins market by product, application, end user, and region.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various recombinant proteins across key geographic regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the recombinant proteins market.
• Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the recombinant proteins market.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Biopharmaceuticals Contract Manufacturing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

  • $ 4750
  • January 2023
  • 168 pages

The biopharmaceuticals contract manufacturing market is expected to register a CAGR of nearly 7.5% during the forecast period. The COVID-19 pandemic has significantly impacted the biopharmaceuticals contract ...

  • World
  • United States
  • Biopharmaceutical
  • Industry analysis
  • Cancer Incidence
  • Health Expenditure


Reportlinker.com © Copyright 2023. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on